Sharp Financial Services’s Novo Nordisk NVO Stock Holding History

Sharp Financial Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,600	Closed	-$387K	–	126
2025 Q4	$387K	Buy	7,600 +1,600	+27%	+$81.8K	0.19%	75
2025 Q3	$333K	Buy	6,000 +2,700	+82%	+$158K	0.18%	77
2025 Q2	$228K	Sell	3,300 -200	-6%	-$13.6K	0.15%	78
2025 Q1	$243K	Buy	3,500 +600	+21%	+$49.6K	0.19%	80
2024 Q4	$249K	Sell	2,900 -2,675	-48%	-$289K	0.19%	82
2024 Q3	$664K	Buy	5,575 +3,575	+179%	+$477K	0.51%	34
2024 Q2	$285K	Buy	+2,000	New	+$265K	0.24%	76

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Sharp Financial Services's NVO Position: Q1 2026 in Review

Sharp Financial Services sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 7,600 shares — an estimated $387K sold.

Sharp Financial Services first reported a position in NVO in Q2 2024 and held it in 7 quarters. The position peaked at $664K in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Sharp Financial Services reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Sharp Financial Services sold 7,600 Novo Nordisk shares in Q1 2026, an estimated $387K.
Sharp Financial Services first reported a position in Novo Nordisk in Q2 2024 and held it in 7 quarters.
Sharp Financial Services's Novo Nordisk position peaked at $664K in Q3 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Sharp Financial Services's 13F filing for Q1 2026, filed 27 Apr 2026.